The Food and Drug Administration today announced a voluntary pilot program to expedite approvals of certain changes to ethylene oxide sterilization processes and facilities. Under the pilot program, facilities that use fixed-chamber ethylene oxide sterilization processes to sterilize single-use medical devices would submit a “master file” to the FDA when making certain changes to their location or changes to their sterilization processes that use lower ethylene oxide concentrations. The FDA believes the program will allow more efficient review and feedback, ultimately allowing the agency to provide a more nimble response to site closures in the future. In addition, FDA said it will work with 12 applicants to its innovation challenges to accelerate the development and review of innovative technologies for sterilization processes, and is moving forward with certain recommendations from its recent advisory committee meeting.

Related News Articles

Headline
The Food and Drug Administration yesterday released an update on Medtronic’s recall of 1,614 devices used to pump blood from the heart to the rest of the…
Headline
The House yesterday voted 392-28 to pass legislation (H.R. 7667) that would reauthorize Food and Drug Administration user fee programs, which provide funding…
Headline
Boston-based venture capital firm Seae Ventures has launched a $107 million fund to invest in women and Black, Indigenous and other historically…
Headline
AHA Maternal and Child Health Council Chair Lara Khouri, executive vice president and chief strategy and transformation officer at Children’s Hospital Los…
Headline
The AHA will present its 2021 Justin Ford Kimball Innovators Award to Spectrum Health, now part of BHSH System, April 25 at the AHA Annual Membership Meeting…
News
Philips Respironics has recalled certain V60 and V60 Plus ventilators because some of them could stop working due to an expired adhesive, the Food and Drug…